Quarterly ResultMay 11, 2026, 04:58 PM
EBR Systems Q1 Net Loss $17.07M; Revenue $2.36M
AI Summary
EBR Systems, Inc. reported a net loss of $17.07 million for Q1 2026, an increase from $10.55 million in Q1 2025. The company generated its first revenue of $2.36 million from its WiSE CRT System following FDA approval in April 2025. Despite this, the company faces substantial doubt about its ability to continue as a going concern due to ongoing operating losses and negative cash flows.
Key Highlights
- Net loss increased to $17.07 million in Q1 2026 from $10.55 million in Q1 2025.
- Revenue for Q1 2026 was $2.36 million, up from $0 in Q1 2025.
- Basic and diluted net loss per share was $(0.38) in Q1 2026, compared to $(0.28) in Q1 2025.
- Net cash used in operating activities was $20.25 million in Q1 2026, up from $13.56 million in Q1 2025.
- Working capital as of March 31, 2026, was $42.0 million, with an accumulated deficit of $419.3 million.
- A 1-for-10 reverse stock split became effective on April 1, 2026, retroactively adjusted in financials.
- The company received U.S. FDA approval for its WiSE CRT System on April 11, 2025.
- Substantial doubt exists regarding the company's ability to continue as a going concern.